Neurochemistry International, Journal Year: 2024, Volume and Issue: 180, P. 105855 - 105855
Published: Sept. 6, 2024
Language: Английский
Neurochemistry International, Journal Year: 2024, Volume and Issue: 180, P. 105855 - 105855
Published: Sept. 6, 2024
Language: Английский
International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(20), P. 11223 - 11223
Published: Oct. 18, 2024
As the global population ages, incidence of neurodegenerative diseases such as Alzheimer’s and Parkinson’s is rapidly rising. These present a significant public health challenge, they severely impair cognitive motor functions, ultimately leading to substantial reduction in quality life placing heavy burden on healthcare systems worldwide. Although several therapeutic agents have been developed manage symptoms these diseases, their effectiveness often limited, there remains an urgent need for preventive strategies. Growing evidence indicates that bioactive compounds from natural products possess neuroprotective properties through antioxidant anti-inflammatory effects, modulating key pathways phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) brain-derived neurotrophic factor–tropomyosin receptor B–cAMP response element-binding protein (BDNF-TrkB-CREB), which are crucial neuronal survival. may also reduce amyloid-beta tau pathology, well enhance cholinergic neurotransmission by inhibiting acetylcholinesterase activity. By targeting oxidative stress, neuroinflammation, neurodegeneration, offer promising approach both prevention treatment. findings suggest be preventing treating diseases. This review aims explore pathogenesis limitations current therapies, potential role agents.
Language: Английский
Citations
8Journal of Ethnopharmacology, Journal Year: 2025, Volume and Issue: 347, P. 119743 - 119743
Published: April 9, 2025
Language: Английский
Citations
0Neurochemistry International, Journal Year: 2024, Volume and Issue: 180, P. 105855 - 105855
Published: Sept. 6, 2024
Language: Английский
Citations
0